Get Lumea's free Digital Pathologists’ Playbook, your step-by-step guide to going digital. The booklet includes step-by-step instructions, vendor lists, specs to keep in mind, how to get a return on investment, and must-attend annual events that will keep you up-to-date on the latest news and tech.
In the pharmaceutical industry, all companies, regardless of their size or area of focus, aim to optimize returns on approved therapies, streamline development processes and minimize trial failures. With the industry poised for further growth and an influx of innovative therapeutics and cell and gene therapies, selecting the most suitable Contract Research Organization (CRO) to form a partnership becomes mission critical.
In a recent study, researchers at Harvard Medical School, Perelman School of Medicine at the University of Pennsylvania, and Cedars-Sinai Medical Center developed a machine learning method for cryosection pathology. The proposed model allowed them to accurately classify gliomas using digital images of cryosection samples during surgery, demonstrating the potential of AI for enabling real-time, intraoperative brain cancer diagnosis.
In an ambitious move to redefine cancer diagnostics and treatment, the UK Prime Minister has announced a transformative £100 million fund designed to accelerate the integration of Artificial Intelligence (AI) in life sciences, with a particular emphasis on cancer diagnostics.
This October, as the vibrant city of Orlando plays host to Pathology Visions 2023 at the prestigious Hyatt Regency, we at Pathology News are filled with anticipation and excitement. From October 29th to 31st, this event, proudly presented by the Digital Pathology Association, promises to be a cornerstone for the latest in digital pathology, bringing together the brightest minds and innovators in the field.
Paige, a global leader in end-to-end digital pathology solutions and clinical AI applications that assist in diagnosing cancer, announced today that the U.S Food and Drug Administration (FDA) has granted Breakthrough Device Designation for Paige Lymph Node, an AI application used to detect breast cancer metastases in lymph node tissue. Paige Lymph Node is the first AI application of its kind to receive Breakthrough Device Designation from the FDA.
Leica Biosystems, a global leader in anatomic pathology, and Paige, a leader in digital pathology software and diagnostic AI applications, previously announced a partnership to create an integrated solution, to expand access to accelerate adoption of digital pathology and artificial intelligence (AI). The companies are now launching their integrated solution at the Digital Pathology Association’s (DPA) Pathology Visions 2023 conference in Orlando, Florida.
Proscia®, a leading provider of digital and computational pathology solutions, has earned ISO 27001 certification. This certification demonstrates the company’s compliance with one of the best-known information security management standards, giving customers added confidence in its products.
It’s time to dispel the myth that slide review is slow with digital pathology, says consultant pathologist Dr. Rebecca Millican-Slater, the Lead Clinician for Cellular Pathology at the St. James’s University Hospital, Leeds, UK.
Aiosyn, a medical software company specializing in AI-powered pathology solutions for cancer and kidney diseases, has announced the formation of its Scientific Advisory Board. The advisory board is being formed to provide scientific and medical guidance for the continued development of Aiosyn’s Kidney AI Suite. Within this platform, Aiosyn is developing AI-powered algorithms that provide objective quantification of kidney lesion scores, with the aim to ultimately improve the efficiency and reproducibility of results.
